The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ocular toxicity with MEK inhibitors in phase I trials: A single centre experience across six clinical trials.
 
Vasiliki Michalarea
No Relationships to Disclose
 
Maria Jose de Miguel Luken
No Relationships to Disclose
 
Nikolaos Diamantis
No Relationships to Disclose
 
Anurag Garg
No Relationships to Disclose
 
Laura Maubon
No Relationships to Disclose
 
Timothy Anthony Yap
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Janssen-Cilag; MSD Oncology
 
L Rhoda Molife
No Relationships to Disclose
 
Johann Sebastian De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - Arno Therapeutics (Inst); AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Paul Ursell
No Relationships to Disclose
 
Udai Banerji
No Relationships to Disclose